Discover how AI healthcare technology and machine learning diagnosis are transforming disease detection, improving accuracy, and reshaping patient care in today's evolving medical landscape.

A team of researchers from Taiwan has developed PanMETAI, an AI-powered platform that analyzes metabolic fingerprints in a ...

Protein Biomarkers May Play an Important Role in Overcoming Limitations of Circulating Tumor DNA for Screening Early-Stage ...

As healthcare systems worldwide grapple with rising cancer rates, chronic diseases and limited clinical resources, ...

Researchers at the Johns Hopkins Kimmel Cancer Center report that an artificial intelligence (AI)-based liquid biopsy test ...

Imagine a screening method that’s more accurate in early detection than a mammogram and less expensive than an MRI. That’s ...

University of Warwick research warns that popular deep learning systems trained for cancer pathology may be relying on hidden ...

A new review highlights how machine learning is transforming the way scientists detect and measure organic pollutants in the ...

New research shows an AI-driven liquid biopsy analyzing genome-wide cfDNA fragment patterns can detect early liver fibrosis & cirrhosis and may signal broader chronic disease burden.

Researchers at the Johns Hopkins Kimmel Cancer Center report that an artificial intelligence (AI)-based liquid biopsy test using genome-wide cell-free DNA (cfDNA) fragmentation patterns and repeat ...

New platform aims to better characterize tumor cell populations that survive therapy and drive cancer relapseDALLAS--(BUSINESS WIRE)--SingleCell Biotechnology, a biotechnology company developing ...